Morepen Laboratories Balance Sheet Annual
BSE: - | NSE: - | ISIN: - | Sector: -62.24 +1.04 (1.70%)Updated : 13 Jul 2026
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 1,936.12 | 1,778.10 | 1,293.21 | 1,110.50 |
| Other Liabilities Total | 44.41 | 44.27 | 38.32 | 33.26 |
| Long Term Debt | 133.60 | 25.76 | 3.36 | 0.93 |
| Common Stock Total | 109.58 | 109.58 | 102.23 | 102.23 |
| Other Current Assets Total | 488.16 | 30.91 | 43.20 | 37.55 |
| Total Assets | 1,936.12 | 1,778.10 | 1,293.21 | 1,110.50 |
| Current Portof LT Debt/ Capital Leases | 69.99 | 19.82 | 2.14 | 1.05 |
| Cash | 31.19 | 27.38 | 16.95 | 21.67 |
| Total Equity | 1,246.44 | 1,156.23 | 847.23 | 752.91 |
| Long Term Investments | 108.84 | 14.94 | 8.44 | 6.38 |
| Retained Earnings( Accumulated Deficit) | 1,136.85 | 501.88 | 383.86 | 287.70 |
| Total Common Shares Outstanding | 54.80 | 54.80 | 51.12 | 51.12 |
| Tangible Book Valueper Share Common Eq | 20.58 | 18.43 | 14.73 | 12.77 |
| Total Liabilities | 689.68 | 621.87 | 445.98 | 357.59 |
| Total Debt | 207.86 | 105.10 | 29.00 | 25.16 |
| Short Term Investments | 38.85 | 77.81 | - | 0.00 |
| Cashand Short Term Investments | 70.04 | 105.19 | 16.95 | 21.67 |
| Total Receivables Net | 333.59 | 396.76 | 356.08 | 297.85 |
| Deferred Income Tax | 16.46 | 6.98 | 2.25 | 2.69 |
| Accounts Receivable- Trade Net | 333.14 | 325.93 | 326.49 | 264.23 |
| Property/ Plant/ Equipment Total- Net | 415.59 | 370.33 | 237.66 | 184.01 |
| Minority Interest | 0.65 | 30.73 | 0.00 | -0.46 |
| Total Current Liabilities | 490.30 | 500.65 | 402.04 | 321.16 |
| Total Inventory | 271.83 | 557.32 | 462.73 | 394.56 |
| Accounts Payable | 317.24 | 363.30 | 295.03 | 226.88 |
| Other Currentliabilities Total | 103.07 | 43.79 | 52.56 | 45.19 |
| Total Long Term Debt | 137.86 | 39.24 | 3.36 | 0.93 |
| Intangibles Net | 118.96 | 72.04 | 19.67 | 25.50 |
| Other Long Term Assets Total | 129.03 | 0.23 | 0.24 | 0.28 |
| Note Receivable- Long Term | 0.08 | 86.70 | 63.68 | 63.69 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 1,163.61 | 1,159.37 | 889.04 | 756.16 |
| Capital Lease Obligations | 4.26 | 13.48 | - | - |
| Accumulated Depreciation Total | - | -275.78 | -261.40 | -328.92 |
| Accrued Expenses | - | 27.71 | 28.82 | 24.86 |
| Other Equity Total | - | -8.40 | -8.65 | -6.81 |
| Prepaid Expenses | - | 69.18 | 10.09 | 4.54 |
| Additional Paid- In Capital | - | 553.16 | 369.79 | 369.79 |
| Property/ Plant/ Equipment Total- Gross | - | 646.11 | 499.06 | 512.93 |
| Goodwill Net | - | 74.47 | 74.47 | 74.47 |
| Notes Payable/ Short Term Debt | - | 46.04 | 23.49 | 23.18 |
| Total Preferred Shares Outstanding | - | - | - | 0.00 |
*All figures in crores except per share values
Morepen Laboratories Quick Links
Morepen Laboratories Dividend Morepen Laboratories Bonus Morepen Laboratories News Morepen Laboratories AGM Morepen Laboratories Rights Morepen Laboratories Splits Morepen Laboratories Board Meetings Morepen Laboratories Key Metrics Morepen Laboratories Shareholdings Morepen Laboratories Profit Loss Morepen Laboratories Cashflow Morepen Laboratories Q1 Results Morepen Laboratories Q2 Results Morepen Laboratories Q3 Results Morepen Laboratories Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
2,180.60+111.55(5.39%)
1,220.45+57.80(4.97%)
1,503.10+47.65(3.27%)
187.25-3.90 (-2.04%)
285.40-4.25 (-1.47%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.